Patents by Inventor Ulrich Porsch

Ulrich Porsch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230270374
    Abstract: A handheld diagnostic device, specifically for point-of-care applications. The handheld diagnostic device comprises at least one diagnostic measurement unit configured for performing at least one diagnostic measurement, the diagnostic measurement unit comprising at least one test element port for determining at least one diagnostic parameter of at least one patient by using at least one diagnostic test element; at least one camera configured for capturing at least one image of at least one wound of the patient; and at least one control unit, the control unit being configured for controlling the diagnostic measurement and for controlling the capturing of the image of the wound, wherein the control unit is further configured for storing at least one measurement result of the diagnostic measurement and the at least one image in at least one database record of the patient. A diagnostic system and a diagnostic method are further disclosed.
    Type: Application
    Filed: May 3, 2023
    Publication date: August 31, 2023
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Michael Maier, Ulrich Porsch, Ralf Schmitz
  • Publication number: 20220406426
    Abstract: A system for providing clinical decision support to a user is presented. The system comprises a Point-of-Care (POC) testing device comprising an integrated clinical decision support module. The POC testing device and the clinical decision support module are connected via a testing module-clinical decision support module interface. The system comprises a testing module between the user and the POC testing device. The testing module requests tests from the user to the POC testing device and sends completed test results from the POC testing device to the user and to the clinical decision support module via the internal interface. The system comprises outside data sources to provide external data via a communication connection to the clinical decision support module of the POC testing device. The clinical decision support module uses the external data and the completed test results to determine and provide clinical decision support information specifically tailored to the user.
    Type: Application
    Filed: August 23, 2022
    Publication date: December 22, 2022
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Florian Schindler, Ian David Parfrement, Ulrich Porsch
  • Publication number: 20220287563
    Abstract: Embodiments related to a self-administered, behavior modification program facilitated through a structured tailoring method and system thereof which accelerates and enhances the internalization process of the individual, and which provides help when the individual begins to fail in adhering or continuing with the behavior modification are disclosed. Program instructions that when executed by a processor causes a processor to initiate automatically a schedule of events of a structured tailoring procedure upon entry criteria being met at some unknown time, provide intervention according to the intervention preferences when the adherence criteria for one of the events has not been met, and end automatically the structured collection procedure upon exit criteria being met at some unknown time.
    Type: Application
    Filed: June 2, 2022
    Publication date: September 15, 2022
    Applicant: Roche Diabetes Care, Inc.
    Inventors: Daniel Wong, David Hasker, Glenn Brassington, Stefan Weinert, Abhishek S. Soni, Alan Greenburg, Paul J. Galley, Ulrich Porsch, Robert E. Reinke, Marco De Polo
  • Patent number: 11382507
    Abstract: Embodiments related to a self-administered, behavior modification program facilitated through a structured tailoring method and system thereof which accelerates and enhances the internalization process of the individual, and which provides help when the individual begins to fail in adhering or continuing with the behavior modification are disclosed. Program instructions that when executed by a processor causes a processor to initiate automatically a schedule of events of a structured tailoring procedure upon entry criteria being met at some unknown time, provide intervention according to the intervention preferences when the adherence criteria for one of the events has not been met, and end automatically the structured collection procedure upon exit criteria being met at some unknown time.
    Type: Grant
    Filed: September 23, 2019
    Date of Patent: July 12, 2022
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Daniel Wong, David Hasker, Glenn Brassington, Stefan Weinert, Abhishek S. Soni, Alan Greenburg, Paul J. Galley, Ulrich Porsch, Robert E. Reinke, Marco De Polo
  • Publication number: 20210295959
    Abstract: A point of care testing (POCT) instrument for analyzing biological samples and a POCT system comprising a plurality of such POCT instruments is proposed. The POCT instrument comprises a housing, a measurement unit designed for collecting data indicative of at least one biological parameter of a biological sample, a main display, and an auxiliary display.
    Type: Application
    Filed: March 18, 2021
    Publication date: September 23, 2021
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Diego Delgrande, Ulrich Porsch, Nina Suter, Mathias Wilhelms
  • Patent number: 10694984
    Abstract: There is provided a test method for analysing a body fluid in which a test tape is used in a test device to successively provide analytical test fields stored on the test tape, wherein body fluid is applied by a user to the test field provided at a time and the said test field is photometrically scanned using a measuring unit of the device to record measurement signals. To increase the measurement reliability, it is proposed that a control value is determined from a time-dependent and/or wavelength-dependent change in the measurement signals and that the measurement signals are processed as valid or discarded as erroneous depending on the control value.
    Type: Grant
    Filed: February 18, 2019
    Date of Patent: June 30, 2020
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Karl Miltner, Robert Lorenz, Ulrich Porsch, Clemens Knapp
  • Publication number: 20200015680
    Abstract: Embodiments related to a self-administered, behavior modification program facilitated through a structured tailoring method and system thereof which accelerates and enhances the internalization process of the individual, and which provides help when the individual begins to fail in adhering or continuing with the behavior modification are disclosed. Program instructions that when executed by a processor causes a processor to initiate automatically a schedule of events of a structured tailoring procedure upon entry criteria being met at some unknown time, provide intervention according to the intervention preferences when the adherence criteria for one of the events has not been met, and end automatically the structured collection procedure upon exit criteria being met at some unknown time.
    Type: Application
    Filed: September 23, 2019
    Publication date: January 16, 2020
    Applicant: Roche Diabetes Care, Inc.
    Inventors: Daniel Wong, David Hasker, Glenn Brassington, Stefan Weinert, Abhishek S. Soni, Alan Greenburg, Paul J. Galley, Ulrich Porsch, Robert E. Reinke, Marco De Polo
  • Patent number: 10522247
    Abstract: Embodiments of methods of assessing a diabetes treatment protocol comprise determining a protocol complexity level corresponding to a degree of difficulty of completing the diabetes treatment protocol by utilizing the processor, determining a patient proficiency level corresponding to a skill set of the patient in conducting the diabetes treatment protocol by utilizing the processor, comparing the protocol complexity level to the patient proficiency level via the processor, and providing an output based on the comparison.
    Type: Grant
    Filed: September 20, 2016
    Date of Patent: December 31, 2019
    Inventors: Paul J. Galley, Stefan Weinert, David Hasker, Ulrich Porsch
  • Patent number: 10456036
    Abstract: Embodiments related to a self-administered, behavior modification program facilitated through a structured tailoring method and system thereof which accelerates and enhances the internalization process of the individual, and which provides help when the individual begins to fail in adhering or continuing with the behavior modification are disclosed. Program instructions that when executed by a processor causes a processor to initiate automatically a schedule of events of a structured tailoring procedure upon entry criteria being met at some unknown time, provide intervention according to the intervention preferences when the adherence criteria for one of the events has not been met, and end automatically the structured collection procedure upon exit criteria being met at some unknown time.
    Type: Grant
    Filed: June 18, 2010
    Date of Patent: October 29, 2019
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Daniel Wong, David Hasker, Glenn Brassington, Stefan Weinert, Abhishek S. Soni, Alan Greenburg, Paul J. Galley, Ulrich Porsch, Robert E. Reinke, Marco De Polo
  • Publication number: 20190298235
    Abstract: There is provided a test method for analysing a body fluid in which a test tape is used in a test device to successively provide analytical test fields stored on the test tape, wherein body fluid is applied by a user to the test field provided at a time and the said test field is photometrically scanned using a measuring unit of the device to record measurement signals. To increase the measurement reliability, it is proposed that a control value is determined from a time-dependent and/or wavelength-dependent change in the measurement signals and that the measurement signals are processed as valid or discarded as erroneous depending on the control value.
    Type: Application
    Filed: February 18, 2019
    Publication date: October 3, 2019
    Applicant: Roche Diabetes Care, Inc.
    Inventors: Karl Miltner, Robert Lorenz, Ulrich Porsch, Clemens Knapp
  • Patent number: 10430613
    Abstract: A blood glucose measuring device and method for transmitting measured bG values to an external device such as a computer with improved data integrity for greater reliability is disclosed. The measuring device comprises a measuring means for determining measured blood glucose values, a measured value memory in which the measured blood glucose values are stored, a data interface that is configured for a data exchange with an external data reading apparatus, and a data file system which comprises a data reading application which can be accessed by the external data reading apparatus in order to read the stored measured blood glucose values, wherein the data system file further comprises a test application that is configured to execute an integrity test for the data reading application by forming a current digital signature for the data reading application and comparing this with a digital test signature provided in the data file system.
    Type: Grant
    Filed: September 3, 2013
    Date of Patent: October 1, 2019
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Karl Werner, Ulrich Porsch, Stefan Riebel
  • Patent number: 10368745
    Abstract: Embodiments of a testing method for diabetics to optimize their administered insulin dosage comprise collecting sampling sets of biomarker data, each sampling set comprising a sufficient plurality of non-adverse sampling instances and each sampling instance comprising an acceptable biomarker reading at a single point in time recorded upon compliance with adherence criteria, determining a biomarker sampling parameter from each sampling set, comparing the biomarker sampling parameter to a target biomarker range, calculating an insulin adjustment parameter associated with the biomarker sampling parameter if the biomarker sampling parameter falls outside the target biomarker range, adjusting the insulin dosage by the insulin adjustment parameter if the biomarker sampling parameter falls outside the target biomarker range and the insulin dosage does not exceed maximum dosage, and exiting the testing method if the adjusted insulin dosage is optimized.
    Type: Grant
    Filed: February 2, 2018
    Date of Patent: August 6, 2019
    Assignee: ROCHE DIABETES CARE INC
    Inventors: Steven Bousamra, Stefan Weinert, Juergen Rasch-Menges, P. Douglas Walling, John F. Price, Heino Eikmeier, Birgit Kraeling, Karl Werner, Ulrich Porsch
  • Publication number: 20190156943
    Abstract: A computer implemented method for localizing handheld analytical devices in a point of care environment is presented. The method comprises associating a location identifier to a plurality of locations within the point of care environment and storing the location identifier into a database, at each of the plurality of locations, capturing signal patterns using signal receiver(s) of the handheld analytical devices, storing all signal patterns captured in a database, capturing a current signal pattern using signal receiver(s) of a handheld analytical device to be localized, and providing a descriptive localization by a control unit indicative of its position relative to one or more of the plurality of locations within the point of care environment associated with one or more signal pattern(s) stored in the database matching the current signal pattern.
    Type: Application
    Filed: November 1, 2018
    Publication date: May 23, 2019
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Gerrit Kocherscheidt, Stephan Korner, Ulrich Porsch, Chris Steinert, Hermann Hofstetter
  • Patent number: 10244970
    Abstract: There is provided a test method for analyzing a body fluid in which a test tape is used in a test device to successively provide analytical test fields stored on the test tape, wherein body fluid is applied by a user to the test field provided at a time and the said test field is photometrically scanned using a measuring unit of the device to record measurement signals. To increase the measurement reliability, it is proposed that a control value is determined from a time-dependent and/or wavelength-dependent change in the measurement signals and that the measurement signals are processed as valid or discarded as erroneous depending on the control value.
    Type: Grant
    Filed: August 12, 2016
    Date of Patent: April 2, 2019
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Karl Miltner, Robert Lorenz, Ulrich Porsch, Clemens Knapp
  • Publication number: 20180168448
    Abstract: Embodiments of a testing method for diabetics to optimize their administered insulin dosage comprise collecting sampling sets of biomarker data, each sampling set comprising a sufficient plurality of non-adverse sampling instances and each sampling instance comprising an acceptable biomarker reading at a single point in time recorded upon compliance with adherence criteria, determining a biomarker sampling parameter from each sampling set, comparing the biomarker sampling parameter to a target biomarker range, calculating an insulin adjustment parameter associated with the biomarker sampling parameter if the biomarker sampling parameter falls outside the target biomarker range, adjusting the insulin dosage by the insulin adjustment parameter if the biomarker sampling parameter falls outside the target biomarker range and the insulin dosage does not exceed maximum dosage, and exiting the testing method if the adjusted insulin dosage is optimized.
    Type: Application
    Filed: February 2, 2018
    Publication date: June 21, 2018
    Applicant: Roche Diabetes Care, Inc.
    Inventors: Steven Bousamra, Stefan Weinert, Juergen Rasch-Menges, P. Douglas Walling, Ajay Thukral, Heino Eikmeier, Birgit Kraeling, Karl Warner, Ulrich Porsch
  • Patent number: 9918635
    Abstract: Embodiments of a testing method suitable for diabetic persons to optimize their administered insulin dosage comprise collecting one or more sampling sets of biomarker data, wherein each sampling set comprises a sufficient plurality of non-adverse sampling instances and wherein each sampling instance comprises an acceptable biomarker reading at a single point in time recorded upon compliance with adherence criteria, determining a biomarker sampling parameter from each sampling set, comparing the biomarker sampling parameter to a target biomarker range, calculating an insulin adjustment parameter associated with the biomarker sampling parameter if the biomarker sampling parameter falls outside the target biomarker range, adjusting the insulin dosage by the insulin adjustment parameter if the biomarker sampling parameter falls outside the target biomarker range and if the insulin dosage does not exceed maximum dosage, and exiting the testing method if the adjusted insulin dosage is optimized.
    Type: Grant
    Filed: June 18, 2010
    Date of Patent: March 20, 2018
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Steven Bousamra, Stefan Weinert, Juergen Rasch-Menges, P. Douglas Walling, John F. Price, Heino Eikmeier, Birgit Kraeling, Karl Werner, Ulrich Porsch
  • Patent number: 9549324
    Abstract: A computer-implemented diabetes management system is provided that supports enhanced security between a diabetes care manager in data communication with a medical device. The diabetes care manager includes: a first application that operates to request access to a first security role supported by the medical device, where the first security role is associated with a first set of commands for accessing data on the medical device that are defined as a private extension of the communication protocol; and a second application that operates to request access to a second security role supported by the medical device, where the second security role is associated with a second set of commands for accessing data on the medical device that are defined as a private extension of the communication protocol. The second set of commands has one or more commands that are mutually exclusive from the first set of commands.
    Type: Grant
    Filed: January 24, 2014
    Date of Patent: January 17, 2017
    Assignee: ROCHE DIABETES CARE, INC.
    Inventors: Daniel Birtwhistle, Thomas D. Gurley, Mark Nierzwick, Ulrich Porsch, John F. Price, Blaine E. Ramey, Raymond Strickland
  • Publication number: 20170011176
    Abstract: Embodiments of methods of assessing a diabetes treatment protocol comprise determining a protocol complexity level corresponding to a degree of difficulty of completing the diabetes treatment protocol by utilizing the processor, determining a patient proficiency level corresponding to a skill set of the patient in conducting the diabetes treatment protocol by utilizing the processor, comparing the protocol complexity level to the patient proficiency level via the processor, and providing an output based on the comparison.
    Type: Application
    Filed: September 20, 2016
    Publication date: January 12, 2017
    Inventors: Paul J. Galley, Stefan Weinert, David Hasker, Ulrich Porsch
  • Publication number: 20160349187
    Abstract: There is provided a test method for analysing a body fluid in which a test tape is used in a test device to successively provide analytical test fields stored on the test tape, wherein body fluid is applied by a user to the test field provided at a time and the said test field is photometrically scanned using a measuring unit of the device to record measurement signals. To increase the measurement reliability, it is proposed that a control value is determined from a time-dependent and/or wavelength-dependent change in the measurement signals and that the measurement signals are processed as valid or discarded as erroneous depending on the control value.
    Type: Application
    Filed: August 12, 2016
    Publication date: December 1, 2016
    Inventors: Karl Miltner, Robert Lorenz, Ulrich Porsch, Clemens Knapp
  • Patent number: 9439587
    Abstract: There is provided a test method for analyzing a body fluid in which a test tape is used in a test device to successively provide analytical test fields stored on the test tape, wherein body fluid is applied by a user to the test field provided at a time and the said test field is photometrically scanned using a measuring unit of the device to record measurement signals. To increase the measurement reliability, it is proposed that a control value is determined from a time-dependent and/or wavelength-dependent change in the measurement signals and that the measurement signals are processed as valid or discarded as erroneous depending on the control value.
    Type: Grant
    Filed: May 4, 2015
    Date of Patent: September 13, 2016
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Karl Miltner, Robert Lorenz, Ulrich Porsch, Clemens Knapp